Oral Pharmaceutical composition comprising acid (e) - 7 - 4 - (4-fluorophenyl) - 6-isopropyl-2 - (methyl - (methylsulphonyl) pyrimidin-5-yl - (3R, 5S) - 3.5 - dihodroxihept - 6enoico,Or a Salt thereof with a formulation containing FERRIC oxide Coating of the coating formulation; use; useful as an inhibitor of HMG CoA reductase.

摘要

Pharmaceutical composition comprising acid (e) - 7 - [4 - (4-fluorophenyl) - 6-isopropyl-2 - [methyl (methylsulfonyl) amino] pyrimidin-5-yl] - (3R, 5S) - 3.5 - dihidroxihepten - 6 - acid,With a Light Protective Coating formulation containing FERRIC oxide; and its use to prevent the formation of degradation products of acid (Divisional Application 2750 - 01).